A renowned researcher of hypertension, diabetes, and genetics
Pavel Hamet, MD, PhD, has studied the interactions between genetics and environment in complex diseases like hypertension and diabetes for over 50 years. Born in Czechia, he earned his MD from Charles University in Prague before coming to Canada in 1967 to pursue his PhD at McGill University and specialize in Endocrinology at Université de Montréal (UdeM). Since becoming a full Professor of Medicine at UdeM in 1983, Dr. Hamet has achieved numerous scientific breakthroughs, including identifying the genetic basis for increased sensitivity to environmental stress and accelerated aging of the vascular system in hypertension. His focus on hypertension, which affects more than 1.3 billion adults today, exemplifies his dedication to improving patient outcomes on a global scale. His diabetes research has been equally influential, contributing to diabetes self-management, insulin pump use, and genomic tests to predict diabetes-related complications. Dr. Hamet’s leadership roles include founding and directing the Centre de recherche du Centre hospitalier de l’UdeM (CRCHUM) from 1990 to 2006, and co-founding CARTaGENE, a population-based biobank advancing personalized medicine. A respected leader in scientific and clinical domains, Dr. Hamet has received over 70 awards for his contributions to detecting, preventing, and treating complex metabolic and endocrine diseases.
About the CMHF
The Canadian Medical Hall of Fame (CMHF) celebrates Canadian heroes whose work advances health in Canada and the world, fostering future generations of health professionals through the delivery of local and national youth education programs and awards.
This enduring tribute to our country’s rich medical history is showcased here and in our physical exhibit hall in London, ON
